EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy

Yeongji Jang, Jiwoong Choi, Byeongmin Park, Jung Yeon Park, Jae-Hyeon Lee, Jagyeong Goo, Dongwon Shin, Sun Hwa Kim, Yongju Kim, Hyun Kyu Song, Jooho Park, Kwangmeyung Kim und 2 weitere

Acta Pharmaceutica Sinica B · 2025-09 · 15 (9) · 4886-4899

DOI: 10.1016/j.apsb.2025.06.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-09. Verfasst von Yeongji Jang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation, Korea Institute of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In light of the burgeoning successes of cancer immunotherapy, glioblastoma (GBM) remains refractory due to an immunosuppressive microenvironment originating from its molecular heterogeneity. Thus, identifying promising therapeutic targets for treating GBM and discovering methodologies to effectively regulate them is still a tremendous challenge. Here we describe photodynamic protein tyrosine phosphatase 1B (PTP1B) proteolysis mediated by a proteolysis-targeting chimera (PROTAC) nanoassembly. The PTP1B-targeting PROTAC is conjugated with a photosensitizer via a cathepsin B (Cat B)-cleavable peptide, which spontaneously forms nanoassemblies due to intermolecular π-π stacking interactions. In GBM models, PROTAC nanoassemblies significantly accumulate in the tumor region across the disrupted blood-brain barrier (BBB), triggering a burst release of the photosensitizer and active PROTAC by Cat B-mediated enzymatic cleavage. Upon laser irradiation, photodynamic therapy (PDT) synergizes with PROTAC-mediated PTP1B proteolysis to induce potent immunogenic cell death (ICD) in tumor cells. Subsequently, persistent PTP1B degradation by nanoassemblies in Cat B-overexpressed intratumoral T cells downregulates exhaustion markers, reinvigorating their functionality. These sequential processes of photodynamic PTP1B proteolysis ultimately augment T cell-mediated antitumor immunity as well as protective immunity, completely eradicating the primary GBM and preventing its recurrence. Overall, our findings underscore the therapeutic potential of combining PDT with PROTAC activity for GBM immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

Cancer immunotherapyNanomedicinePhotodynamic therapyProdrugProtein tyrosine phosphatase 1BProteolysis-targeting chimeraSupramolecular assemblyTargeted protein degradation

Autor:innen und Institutionen

  • Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.
  • Department of Life Sciences, Korea University, Seoul 02841, Republic of Korea.
  • KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea.
  • Department of Applied Life Science, BK21 Program, Konkuk University, Chungju 27478, Republic of Korea.
  • College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
  • Chemical and Biological Integrative Research Center, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea.

Förderung

  • National Research Foundation
  • Korea Institute of Science and Technology

Zitieren

APA

Jang, Y., Choi, J., Park, B., Park, J. Y., Lee, J. H., Goo, J., Shin, D., Kim, S. H., Kim, Y., Song, H. K., Park, J., Kim, K., Yang, Y., & Shim, M. K. (2025). Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy. Acta Pharmaceutica Sinica B, 15(9), 4886-4899. https://doi.org/10.1016/j.apsb.2025.06.028

Vancouver

Jang Y, Choi J, Park B, Park JY, Lee JH, Goo J, et al. Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy. Acta Pharmaceutica Sinica B. 2025;15(9):4886-4899. doi:10.1016/j.apsb.2025.06.028

BibTeX
@article{Jang2025,
  author = {Jang, Yeongji and Choi, Jiwoong and Park, Byeongmin and Park, Jung Yeon and Lee, Jae-Hyeon and Goo, Jagyeong and Shin, Dongwon and Kim, Sun Hwa and Kim, Yongju and Song, Hyun Kyu and Park, Jooho and Kim, Kwangmeyung and Yang, Yoosoo and Shim, Man Kyu},
  title = {Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2025},
  volume = {15},
  number = {9},
  pages = {4886--4899},
  doi = {10.1016/j.apsb.2025.06.028}
}
Kostenlos starten →